- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Red Light Holland Corp.: Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments | 306 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and... ► Artikel lesen | |
| FILAMENT HEALTH Aktie jetzt für 0€ handeln | |||||
| Mo | Red Light Holland Corp.: Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate | 305 | Newsfile | Study conducted under U.S. FDA Investigational New Drug (IND) authorization by Dr. Anthony Back at the University of WashingtonSecond psilocybin session showed meaningful improvements in anxiety... ► Artikel lesen | |
| 07.04. | Red Light Holland Corp.: Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments | 491 | Newsfile | Three new license agreements signed and two research shipments completed in March 2026, spanning institutions in Australia, the United Kingdom, and CanadaToronto, Ontario--(Newsfile Corp. - April... ► Artikel lesen | |
| 01.04. | Red Light Holland Corp.: Red Light Holland to Support University of California San Francisco's Global Psychedelic Study Through Filament Health's Clinical Network | 542 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that, through Filament Health Corp.... ► Artikel lesen | |
| 23.03. | Red Light Holland Corp.: Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement | 362 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament")... ► Artikel lesen | |
| 18.03. | Red Light Holland Corp.: Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate | 664 | Newsfile | AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industryToronto... ► Artikel lesen | |
| 16.03. | Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression | 966 | ACCESS Newswire | Whole leaf coca extract under evaluation is Magdalena's drug candidate for post-GLP-1 weight loss management SAN FRANCISCO, CA / ACCESS Newswire / March 16, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX)... ► Artikel lesen | |
| 10.03. | Red Light Holland Corp.: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation | 596 | Newsfile | Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering... ► Artikel lesen | |
| 07.11.25 | Filament Health Announces Third Quarter 2025 Financial Results And Operational Highlights | 5 | CNW | ||
| 08.07.25 | Jaguar Health, Inc.: Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health | 654 | ACCESS Newswire | Magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications SAN FRANCISCO, CA / ACCESS Newswire / July 8, 2025 /
Jaguar Health, Inc.
(NASDAQ:JAGX)
... ► Artikel lesen | |
| 22.05.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.05.2025 | 932 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.05.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.05.2025.ISIN NameCA31685W1068 FILAMENT... ► Artikel lesen | |
| 22.05.25 | XFRA 7QS: AUSSETZUNG/SUSPENSION | 340 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILFILAMENT HEALTH... ► Artikel lesen | |
| 19.05.25 | Filament Health Corp.: Filament Health Announces Voluntary Delisting From Cboe Canada | 298 | PR Newswire | VANCOUVER, BC, May 19, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen | |
| 09.05.25 | Filament Health Corp.: Filament Health Announces First Quarter 2025 Financial Results And Operational Highlights | 220 | PR Newswire | VANCOUVER, BC, May 8, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (CBOE: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 38,500 | -3,85 % | Bayer, MustGrow Biologics und Yara International: So holen Sie sich den 40 % Dünger-Preissprung in Ihr Portfolio | Seit Ende Februar 2026 blockiert der Iran-Krieg die Straße von Hormuz und katapultiert Stickstoffdüngerpreise um 40 % nach oben. Während geopolitische Schocks die Lieferketten zerreißen, entstehen für... ► Artikel lesen | |
| AURORA CANNABIS | 2,872 | -0,62 % | Nach den Tilray-Zahlen: Aurora, Canopy & Co. vor richtungsweisender Berichtssaison | In einer Phase, in der sich das Handelsgeschehen auf die Auswirkungen des Iran-Krieges zu konzentrieren scheint, nimmt die Quartalsberichtssaison Fahrt auf. Für die Cannabis-Unternehmen wird es möglicherweise... ► Artikel lesen | |
| CANOPY GROWTH | 1,016 | +0,74 % | Canopy Growth Corp (2): Canopy Growth launches Tweed brand summer campaign | ||
| TILRAY BRANDS | 5,800 | +0,87 % | Tilray-Aktie: Neue Verkaufswelle in Anmarsch? | Nach einem Hochpunkt im Handelsjahr 2025 bei 23,20 US$ verabschiedete sich die Tilray-Aktie von eben diesen Kursniveaus und rauschte unter hoher Volatilität bis zum finalen Tief des Vormonats bei 5... ► Artikel lesen | |
| INNOCAN PHARMA | 3,910 | -3,22 % | InnoCan Pharma unter massivem Druck: 0,4% Verlust und das könnte erst der Anfang sein - Die Fakten auf einen Blick! | ||
| CRONOS GROUP | 2,306 | +0,96 % | Cronos Group Inc: Cronos to hold Q1 results call May 11 | ||
| SYNBIOTIC | 2,010 | 0,00 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr 2026 | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Prognose
SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,230 | +0,48 % | Green Thumb Industries Inc: Green Thumb adds $100-million of share buyback capacity | ||
| CHRISTINA LAKE CANNABIS | 0,025 | +194,12 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| AXSOME THERAPEUTICS | 160,85 | +1,42 % | Axsome Inks Agreement To Obtain Exclusive Global Rights To TAK-063 From Takeda | TOKYO (dpa-AFX) - Biopharmaceutical company Axsome Therapeutics, Inc. (AXSM) announced Wednesday that it has entered into an asset purchase agreement to obtain exclusive global rights to TAK-063... ► Artikel lesen | |
| JAZZ PHARMACEUTICALS | 167,30 | -0,21 % | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026 | DUBLIN, April 21, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced its 2026 first quarter financial results will be reported on Tuesday, May 5, 2026, after the... ► Artikel lesen | |
| JAGUAR HEALTH | 0,390 | -1,22 % | Jaguar Health, Inc.: Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition | Intestinal Failure (IF) occurs in patients with an ultrarare congenital enteropathy due to microvillus inclusion disease (MVID) and/or short bowel syndrome (SBS)Jaguar has received orphan drug designations... ► Artikel lesen | |
| TRULIEVE CANNABIS | 7,400 | +0,96 % | Trulieve Cannabis Corp: Trulieve welcomes U.S. medical marijuana rescheduling | ||
| CORBUS PHARMACEUTICALS | 8,745 | +1,63 % | Clean Energy Fuels appoints Clay Corbus as CEO | ||
| AVALO THERAPEUTICS | 12,340 | +3,70 % | Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates | Topline data expected from Phase 2 LOTUS trial of abdakibart (AVTX-009) for the treatment of hidradenitis suppurativa in the second quarter of 2026Cash, cash equivalents and short-term investments... ► Artikel lesen |
FILAMENT HEALTH CORP gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,010 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FILAMENT HEALTH CORP finden Sie auf Wallstreet Online.